NYSE · Analyst Forecast

Organon & Co. (OGN) Stock Forecast & Price Target

$13.90 NYSE: OGN Market Cap $3.65B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Organon & Co. (OGN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Organon & Co., analysts forecast revenue rising from $6.22B in 2025 to $6.50B in 2030; the average estimate for 2030 earnings per share is $3.90; with published estimates ranging from $3.84 to $3.97; 6 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$13.90
Consensus targetThe average of the price targets analysts have published.$11.33
Median targetThe middle target, less affected by a single outlier.$12.00
Highest targetThe most optimistic published target.$14.00
Lowest targetThe most pessimistic published target.$8.00
Difference from priceHow far the consensus target sits from today’s price.-18.5%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$6.21B$6.22B$6.23B6
2026$6.05B$6.13B$6.22B3
2027$6.25B$6.36B$6.46B3
2028$6.49B$6.68B$6.93B3
2029$6.39B$6.46B$6.55B1
2030$6.43B$6.50B$6.59B2

Earnings per share forecast

YearLowAverageHighAnalysts
2025$3.62$3.75$3.846
2026$3.31$3.35$3.403
2027$3.43$3.63$3.823
2028$3.95$4.01$4.083
2029$3.74$3.80$3.871
2030$3.84$3.90$3.972

Organon & Co. (OGN) forecast — frequently asked questions

What is the analyst price target for Organon & Co.?

Analysts covering Organon & Co. (OGN) have a consensus price target of $11.33, 18.5% below the current price of $13.90. Published targets range from $8.00 to $14.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Organon & Co.'s earnings?

The average analyst estimate for Organon & Co. (OGN) earnings per share in 2030 is 3.90, with individual estimates between 3.84 and 3.97.

How much revenue is Organon & Co. expected to make?

Analysts forecast Organon & Co. (OGN) revenue of $6.50B in 2030, based on 2 published estimates.

How many analysts cover OGN?

6 analysts contribute estimates for Organon & Co. (OGN). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastMRK forecastNVS forecastAZN forecastAMGN forecastGILD forecastNVO forecastPFE forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.